Companies / Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc.

Nasdaq: RCKTCIK 1281895NEW YORK, NY

Financials · FY2025

Revenue$0
Net income$-223.12M
Total debt—
Cash$224.51M
Diluted EPS$-2.01
Shares outstanding109.8M

Ownership

109.8M shares outstanding · as of Jul 31, 2026
2.0%Insiders
Ownership
Insiders2.01%2,208,830
10%+ / strategic7.78%8,544,423
Institutions82.22%90,261,108
Public float7.98%8,760,236

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Shah GauravCEOCEO
0.97%1,061,724
Wilson MartinGeneral Counsel
0.62%677,977
Stevens Christopher JamesChief Operating Officer
0.43%469,129
Rizvi Syed Ali-aamirFormerChief Medical Officer
0.37%407,874
Chaudhuri SarbaniFormerSee Remarks
0.24%267,510
Militello JohnFormerSee Remarks
0.08%89,780
Bjork ElisabethFormerDirector
0.05%50,000

Institutional holders 193

View all →
HolderValue% of shares
RTW Investments, LP$62.08M16.11%
BlackRock, Inc.$33.94M9.04%
Vanguard Group Inc$29.99M7.78%
Citigroup Inc$18.41M4.78%
Morgan Stanley$13.83M3.59%
Millennium Management LLC$11.16M2.84%
AQR Capital Management, LLC$10.99M2.80%
Marshall Wace, LLP$10.88M2.77%
Suvretta Capital Management, LLC$10.50M2.73%
Newtyn Management, LLC$9.30M2.41%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 21, 2026Shah Gaurav
CEO
SellCommon Stock$171.8K-56K
-4.98%
1,061,724
0.97% of shares
medium
May 21, 2026Shah Gaurav
CEO
ExerciseCommon Stock$129.3K+76K
+7.35%
1,117,408
1.02% of shares
low
May 7, 2026Chaudhuri Sarbani
Executive
SellCommon Stock$67.7K-18K
-6.19%
267,510
0.24% of shares
low
Feb 13, 2026Shah Gaurav
CEO
SellCommon Stock$40.7K-12K
-1.15%
1,052,045
0.96% of shares
low
Feb 13, 2026Wilson Martin
Executive
SellCommon Stock$40.6K-12K
-1.76%
683,376
0.62% of shares
low
Jan 2, 2026Bjork Elisabeth
Director
BuyCommon Stock$34.4K+10K
+25.00%
50,000
0.05% of shares
low
Feb 18, 2026Shah Gaurav
CEO
SellCommon Stock$20.0K-6K
-0.57%
1,046,055
0.95% of shares
low
Feb 13, 2026Militello John
Executive
SellCommon Stock$12.3K-4K
-3.89%
92,176
0.08% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—8,544,423—
Vanguard Group IncPassive13G/A—0—
Maverick Capital LtdPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
RCKT——77313F106—